Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.66M | -8.74M | -8.30M | -14.67M | -18.34M |
| Total Depreciation and Amortization | 4.17M | 3.92M | 3.67M | 3.42M | 3.26M |
| Total Amortization of Deferred Charges | 442.00K | 406.00K | 346.00K | 307.00K | 215.00K |
| Total Other Non-Cash Items | 5.51M | 4.76M | 5.69M | 5.58M | 4.98M |
| Change in Net Operating Assets | -5.39M | -3.06M | -8.34M | -3.77M | -17.99M |
| Cash from Operations | -3.93M | -2.71M | -6.94M | -9.13M | -27.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -15.00M | -15.00M | -15.00M | 0.00 |
| Cash from Investing | -15.00M | -15.00M | -15.00M | -15.00M | 0.00 |
| Total Debt Issued | 5.05M | 5.00M | 10.00M | 10.00M | 19.95M |
| Total Debt Repaid | -1.25M | -1.88M | -1.88M | -1.25M | -625.00K |
| Issuance of Common Stock | 17.74M | 11.01M | 10.88M | 8.29M | 6.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -125.00K | -50.00K | -50.00K | -50.00K | -380.00K |
| Cash from Financing | 21.42M | 14.09M | 18.95M | 16.99M | 25.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.49M | -3.62M | -2.99M | -7.13M | -2.29M |